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A novel ﬂow cytometric assay for rapid detection of extended-spectrum beta-lactamases
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Abstract
The rapid detection of extended-spectrum beta-lactamases (ESBLs) is a challenge for most clinical microbiology laboratories because
inaccurate identiﬁcation of ESBL producers has important clinical implications for both antibiotic treatment and infection control. The aim of
our study was to develop a rapid detection assay of ESBL producers based upon ﬂow cytometric analysis. Antimicrobial susceptibility testing
followed by molecular characterization of blaTEM, blaSHV or blaCTX-M genes was performed on clinical isolates (41 ESBL positive and 20 ESBL
negative) and isolates expressing well-characterized beta-lactamases, including ESBLs (n = 13), plasmid AmpCs (n = 3), oxacillinases (n = 5)
and carbapenemases (n = 3). Additionally, two ATCC strains recommended by CLSI for susceptibility testing were used as controls. The
ﬂow cytometry analysis protocol involved an incubation of bacterial cells with different concentrations of ceftazidime (1, 2 and 4 mg/L) and
cefotaxime (4, 8 and 16 mg/L) for 1 and 2 hours, in the presence and absence of clavulanic acid; subsequently, cells were stained with the
ﬂuorescent dye Bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)], a lipophilic anion able to diffuse across depolarized
membranes. Additionally, CFU counts were performed. Susceptible isolates displayed increased ﬂuorescence after 1 hour of incubation;
conversely, the increase of the depolarized population was only observed after incubation with clavulanic acid associated with ceftazidime or
cefotaxime in ESBL producers. An excellent correlation was obtained between the number of non-depolarized bacteria quantiﬁed by ﬂow
cytometry and by conventional CFU assays. A novel, accurate and fast ﬂow cytometric assay is available to detect the presence of ESBLs.
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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated (HA), community-associated (CA) and livestock-
associated (LA) infections. Recently, the discovery of human and bovine MRSA isolates carrying a new mecA gene homologue, mecALGA251
(now designated mecC), has caused concern because they are not detected by conventional, conﬁrmatory tests for MRSA. Very little is
known about their frequency, epidemiology and possible transmission between livestock and humans. In this study, the epidemiology of the
mecC isolates in Denmark was investigated by screening the national collections of MRSA cases (from 1988 onwards) and S. aureus
bacteraemia cases (from 1958 onwards). Isolates carrying mecC were only recovered infrequently before 2003 (n = 2) but now seem to be
increasing, with 110 cases in 2003 –2011. Clinical data on mecC-carrying MRSA demonstrated that mecC-MRSA were primarily community-
acquired (CA-MRSA) and affected persons typically living in rural areas, being older than other CA-MRSA patients. Among 22 cases in
Region Zealand, four reported contact with cattle and sheep. Two of these persons lived on farms with livestock positive for mecC-carrying
MRSA, sharing spa type (t843), MLVA (MT429) and PFGE pattern with the human isolates. These observations indicate that mecC-carrying
MRSA can be exchanged between humans and ruminants.
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Abstract
Carbapenem-resistant Klebsiella pneumoniae (CR-KP) is becoming a common cause of healthcare-associated infection in Italy, with high
morbidity and mortality. Prevalent CR-KP clones and resistance mechanisms vary between regions and over time. Therapeutic approaches
and their impact on mortality have to be investigated. We performed a prospective study of patients with CR-KP isolation, hospitalized in
nine hospitals of Rome, Italy, from December 2010 to May 2011, to describe the molecular epidemiology, antibiotic treatment and risk
factors for mortality. Overall, 97 patients (60% male, median age 69 years) were enrolled. Strains producing blaKPC-3 were identiﬁed in 89
patients, blaVIM in three patients and blaCTX-M-15 plus porin defects in the remaining ﬁve patients. Inter-hospital spread of two major
clones, ST512 and ST258, was found. Overall, 36.1% and 20.4% of strains were also resistant to colistin and tigecycline, respectively.
Infection was diagnosed in 91 patients who received appropriate antibiotic treatment, combination therapy and removal of the infectious
source in 73.6%, 59.3% and 28.5% of cases, respectively. Overall, 23 different antibiotic regimens were prescribed. In-hospital mortality was
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25.8%. Multivariate analysis adjusted for appropriate treatment, combination therapy and infectious-source removal, showed that Charlson
comorbidity score, intensive-care unit onset of infection, bacteraemia and infection due to a colistin-resistant CR-KP strain were
independent risk factors for mortality. The spread of clones producing K. pneumoniae carbapenemases, mainly ST258, is currently the major
cause of CR-KP infection in central Italy. We observed a high rate of resistance to colistin that is independently associated with worse
outcome.
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